Novo's Wegovy reduced liver fat to normal levels in trial
Novo Nordisk said Wegovy reduced liver fat to normal levels in 9 out of 10 adults with obesity and excess liver fat, according to EASD2026.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.